LKT Labs, 1256580-46-7, Biologically Active Small Molecules

Sort
View
Show
  • LKT Labs

    CH5424802 is an inhibitor of anaplastic lymphoma kinase (ALK) that displays anticancer chemotherapeutic and anti-metastatic activities against WT and L1196M mutant ALK. This compound is in clinical trials as a potential treatment for various cancers. CH5424802 induces regression of non-small cell…